Joint Stock Company Farmak

Where the EU money came from

Funding by EU programme. Amounts are Joint Stock Company Farmak's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• ORBISPartner

  Open Research Biopharmaceutical Internships Support

  Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  €189ktheir share
• VAHVISTUSPartner

  Integrative development of smart drug-vector nanostructures for adaptive delivery to target cells

  Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  €244ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Helsingin YliopistoFinland · 2 shared projects
• Consiglio Nazionale Delle RicercheItaly · 1 shared project
• The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near DublinIreland · 1 shared project
• Univerza V LjubljaniSlovenia · 1 shared project
• Vysoka Skola Chemicko-Technologicka V PrazeCzech Republic · 1 shared project
• Politechnika PoznanskaPoland · 1 shared project
• Uniwersytet Medyczny im Karola Marcinkowskiego W PoznaniuPoland · 1 shared project
• University of FloridaUnited States · 1 shared project
• Universite Sidi Mohammed Ben AbdellahMorocco · 1 shared project
• Zentiva KsCzech Republic · 1 shared project
• Siec Badawcza Lukasiewicz - Instytut FarmaceutycznyPoland · 1 shared project
• Ibn Tofail UniversityMorocco · 1 shared project
• Rutgers, the State University of New JerseyUnited States · 1 shared project
• Institute of Organic Chemistry of National Academy Sciences of UkraineUkraine · 1 shared project
• Physiolution GmbHGermany · 1 shared project
• Celon Pharma SAPoland · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• drug discovery
• nanomedicine
• nanotechnology
• oncology
• pharmacokinetics
• physical chemistry
• productivity